Jun 01, 2021 / 06:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. Good afternoon. Thanks, everybody, for joining us. Welcome to Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandy Couillard. I cover the life science tools and diagnostics sector here at the firm. Very pleased to have Agilent with us back at the conference this year. Joining us for this conversation, CFO, Bob McMahon.
Bob, thanks for joining us.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Thanks, Brandon, and good afternoon, everyone. Certainly a pleasure to have a chance to talk to you about Agilent and the business going forward.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystFor anybody that's on the line, if you'd like, please feel free to e-mail me a question that you might have, and we'll do our best to try to work those in.
Bob, just to kick off, I mean, Agilent has remained quite resilient in terms of top line growth. From